Evaluation model for predicting risk of gestational diabetes mellitus and application thereof
The invention discloses an evaluation model for predicting the risk of gestational diabetes mellitus and application thereof, belongs to the technical field of biomedicine, and discloses a product for predicting the risk of gestational diabetes mellitus, the product comprises a reagent for detecting...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses an evaluation model for predicting the risk of gestational diabetes mellitus and application thereof, belongs to the technical field of biomedicine, and discloses a product for predicting the risk of gestational diabetes mellitus, the product comprises a reagent for detecting the expression level of a biomarker, the biomarkers comprise fasting blood glucose (FPG), total cholesterol (TC), lipoprotein (Lipoprotein) and a G protein coupled receptor 120 (GPR120). The model constructed by the invention is logit (Y) = 2.504 * FPGA + 1.528 * TC + 0.019 * Lipoprotein + 0.544 * GPR120-30.625, and compared with a traditional model, the model shows a better prediction value for the attack of gestational diabetes mellitus (GDM) in the early stage of pregnancy, and is beneficial to early recognition of high-risk GDM crowds in clinic.
本发明公开了一种用于预测妊娠期糖尿病风险的评估模型及其应用,属于生物医学技术领域,本发明公开了一种用于预测妊娠期糖尿病患病风险的产品,所述产品包括检测生物标志物表达水平的试剂,所述生物标志物包括空腹血糖(FPG)、总胆固醇(TC)、脂蛋白(Lipoprotein)和G蛋白偶联受体120(GPR120)。本发明构建的模型为logit( |
---|